Hoth Therapeutics, Inc.
HOTH
$1.23
-$0.0198-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.89% | 7.67% | 17.91% | -12.97% | -16.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.43% | 22.66% | 5.61% | -15.31% | -20.70% |
| Operating Income | -28.43% | -22.66% | -5.61% | 15.31% | 20.70% |
| Income Before Tax | -28.89% | -20.23% | -3.28% | 17.36% | 22.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.89% | -20.23% | -3.28% | 17.36% | 22.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.89% | -20.23% | -3.28% | 17.36% | 22.33% |
| EBIT | -28.43% | -22.66% | -5.61% | 15.31% | 20.70% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 39.83% | 45.05% | 45.06% | 68.34% | 71.09% |
| Normalized Basic EPS | 39.67% | 43.58% | 43.66% | 65.34% | 69.16% |
| EPS Diluted | 39.70% | 44.99% | 45.00% | 68.32% | 71.07% |
| Normalized Diluted EPS | 39.67% | 43.58% | 43.66% | 65.34% | 69.16% |
| Average Basic Shares Outstanding | 109.90% | 117.61% | 87.08% | 113.28% | 128.36% |
| Average Diluted Shares Outstanding | 109.90% | 117.61% | 87.08% | 113.28% | 128.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |